Mitsui Chemicals Inc
TSE:4183
Mitsui Chemicals Inc
TSE:4183
Price:
3 386
JPY
0.83%
Market Closed
Market Cap:
643.9B
JPY
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
Alert
Mitsui Chemicals Inc
3386
+28 (+0.83%)
| 52 Week Range |
3 211
4 777
|
| Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
Mitsui Chemicals Inc
Balance Sheet
Balance Sheet Decomposition
Mitsui Chemicals Inc
Mitsui Chemicals Inc
| Current Assets | 1T |
| Cash & Short-Term Investments | 207.4B |
| Receivables | 318.7B |
| Other Current Assets | 486.9B |
| Non-Current Assets | 1.1T |
| Long-Term Investments | 266.1B |
| PP&E | 657.3B |
| Intangibles | 81B |
| Other Non-Current Assets | 86.1B |
| Current Liabilities | 554.1B |
| Accounts Payable | 157.9B |
| Other Current Liabilities | 396.3B |
| Non-Current Liabilities | 687.5B |
| Long-Term Debt | 447.8B |
| Other Non-Current Liabilities | 239.8B |
Balance Sheet
Mitsui Chemicals Inc
Mitsui Chemicals Inc
Currency: JPY
| Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
52 004
|
79 578
|
84 120
|
80 209
|
111 056
|
163 983
|
193 585
|
179 754
|
185 377
|
210 292
|
|
| Cash Equivalents |
52 004
|
79 578
|
84 120
|
80 209
|
111 056
|
163 983
|
193 585
|
179 754
|
185 377
|
210 292
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
37 393
|
29 578
|
44 894
|
77 342
|
40 052
|
|
| Total Receivables |
369 212
|
289 459
|
323 454
|
366 582
|
365 161
|
284 992
|
290 938
|
386 352
|
376 356
|
388 826
|
|
| Accounts Receivables |
298 231
|
244 546
|
271 175
|
306 226
|
309 873
|
261 497
|
274 902
|
357 221
|
339 843
|
356 483
|
|
| Other Receivables |
70 981
|
44 913
|
52 279
|
60 356
|
55 288
|
23 495
|
16 036
|
29 131
|
36 513
|
32 343
|
|
| Inventory |
291 295
|
240 686
|
247 544
|
274 342
|
301 890
|
284 306
|
258 814
|
369 009
|
441 949
|
451 075
|
|
| Other Current Assets |
19 197
|
18 487
|
23 820
|
10 193
|
8 570
|
11 160
|
14 657
|
53 436
|
13 262
|
61 168
|
|
| Total Current Assets |
731 708
|
628 210
|
678 938
|
731 326
|
786 677
|
781 834
|
787 572
|
1 033 445
|
1 094 286
|
1 150 579
|
|
| PP&E Net |
433 629
|
413 402
|
409 429
|
432 908
|
443 063
|
499 650
|
501 960
|
553 584
|
600 887
|
652 098
|
|
| PP&E Gross |
433 629
|
413 402
|
409 429
|
432 908
|
443 063
|
499 650
|
501 960
|
553 584
|
600 887
|
652 098
|
|
| Accumulated Depreciation |
1 179 249
|
1 153 727
|
1 154 163
|
1 163 826
|
1 194 034
|
1 300 288
|
1 334 109
|
1 431 968
|
1 429 839
|
1 413 078
|
|
| Intangible Assets |
37 785
|
30 765
|
27 781
|
25 792
|
24 324
|
24 759
|
19 678
|
45 341
|
48 137
|
55 241
|
|
| Goodwill |
34 978
|
9 408
|
7 407
|
5 684
|
5 061
|
1 476
|
1 123
|
17 981
|
19 338
|
21 169
|
|
| Long-Term Investments |
122 919
|
129 066
|
143 501
|
159 428
|
165 199
|
173 752
|
178 194
|
210 460
|
229 123
|
239 260
|
|
| Other Long-Term Assets |
50 771
|
48 097
|
58 469
|
76 171
|
76 750
|
49 044
|
69 598
|
74 154
|
76 432
|
97 472
|
|
| Other Assets |
34 978
|
9 408
|
7 407
|
5 684
|
5 061
|
1 476
|
1 123
|
17 981
|
19 338
|
21 169
|
|
| Total Assets |
1 411 790
N/A
|
1 258 948
-11%
|
1 325 525
+5%
|
1 431 309
+8%
|
1 501 074
+5%
|
1 530 515
+2%
|
1 558 125
+2%
|
1 934 965
+24%
|
2 068 203
+7%
|
2 215 819
+7%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
164 193
|
118 331
|
145 658
|
162 179
|
163 908
|
117 920
|
117 750
|
173 032
|
161 197
|
177 039
|
|
| Accrued Liabilities |
93
|
164
|
140
|
158
|
175
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
122 062
|
86 490
|
90 276
|
114 348
|
102 733
|
179 829
|
162 182
|
297 437
|
324 120
|
289 627
|
|
| Current Portion of Long-Term Debt |
56 334
|
46 034
|
42 724
|
40 260
|
57 997
|
52 964
|
54 539
|
49 178
|
44 343
|
34 461
|
|
| Other Current Liabilities |
105 817
|
113 240
|
113 985
|
126 160
|
133 945
|
134 961
|
131 834
|
186 922
|
165 784
|
175 452
|
|
| Total Current Liabilities |
448 499
|
364 259
|
392 783
|
443 105
|
458 758
|
485 674
|
466 305
|
706 569
|
695 444
|
676 579
|
|
| Long-Term Debt |
368 996
|
339 299
|
304 228
|
305 963
|
321 288
|
313 237
|
293 495
|
319 471
|
369 786
|
432 670
|
|
| Deferred Income Tax |
24 421
|
19 791
|
24 169
|
13 240
|
11 471
|
23 017
|
27 834
|
28 133
|
35 162
|
42 136
|
|
| Minority Interest |
65 064
|
61 266
|
64 943
|
75 636
|
79 824
|
80 487
|
74 236
|
94 468
|
96 476
|
121 955
|
|
| Other Liabilities |
98 575
|
92 362
|
89 710
|
81 779
|
77 818
|
98 880
|
88 334
|
73 670
|
84 508
|
79 628
|
|
| Total Liabilities |
1 005 555
N/A
|
876 977
-13%
|
875 833
0%
|
919 723
+5%
|
949 159
+3%
|
1 001 295
+5%
|
950 204
-5%
|
1 222 311
+29%
|
1 281 376
+5%
|
1 352 968
+6%
|
|
| Equity | |||||||||||
| Common Stock |
125 053
|
125 053
|
125 053
|
125 125
|
125 205
|
125 298
|
125 331
|
125 414
|
125 572
|
125 738
|
|
| Retained Earnings |
165 408
|
181 128
|
236 961
|
291 000
|
348 202
|
359 794
|
424 084
|
516 098
|
575 125
|
617 400
|
|
| Additional Paid In Capital |
91 065
|
90 847
|
90 491
|
89 327
|
89 406
|
79 320
|
74 009
|
69 866
|
57 778
|
55 027
|
|
| Unrealized Security Profit/Loss |
21 018
|
0
|
20 337
|
26 558
|
21 421
|
0
|
0
|
0
|
19 416
|
25 385
|
|
| Treasury Stock |
14 454
|
0
|
14 708
|
19 842
|
29 869
|
39 254
|
24 900
|
34 932
|
32 704
|
32 751
|
|
| Other Equity |
18 145
|
15 100
|
8 442
|
582
|
2 450
|
4 062
|
9 397
|
36 208
|
41 640
|
72 052
|
|
| Total Equity |
406 235
N/A
|
381 971
-6%
|
449 692
+18%
|
511 586
+14%
|
551 915
+8%
|
529 220
-4%
|
607 921
+15%
|
712 654
+17%
|
786 827
+10%
|
862 851
+10%
|
|
| Total Liabilities & Equity |
1 411 790
N/A
|
1 258 948
-11%
|
1 325 525
+5%
|
1 431 309
+8%
|
1 501 074
+5%
|
1 530 515
+2%
|
1 558 125
+2%
|
1 934 965
+24%
|
2 068 203
+7%
|
2 215 819
+7%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
200
|
200
|
200
|
199
|
195
|
191
|
196
|
193
|
190
|
190
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
